KIA
KLR Investment Advisors Portfolio holdings
AUM
$138M
This Quarter Return
+9.91%
1 Year Return
+25.86%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(-0.04%)
Cap. Flow
-$4.78M
Cap. Flow
% of AUM
-3.45%
Top 10 Holdings %
Top 10 Hldgs %
33.3%
Holding
205
New
24
Increased
40
Reduced
116
Closed
20
Top Buys
| 1 |
Panagram BBB-B CLO ETF
CLOZ
|
$3.3M |
| 2 |
Franklin International Core Dividend Tilt Index ETF
DIVI
|
$1.6M |
| 3 |
DoubleLine Commercial Real Estate ETF
DCRE
|
$1.27M |
| 4 |
Vanguard Small-Cap Growth ETF
VBK
|
$985K |
| 5 |
RELX
RELX
|
$827K |
Top Sells
| 1 |
Sprott Uranium Miners ETF
URNM
|
$3.93M |
| 2 |
Novartis
NVS
|
$1.77M |
| 3 |
SAP
SAP
|
$1.52M |
| 4 |
Shell
SHEL
|
$1.22M |
| 5 |
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
|
$550K |
Sector Composition
| 1 | Technology | 16.29% |
| 2 | Healthcare | 7.32% |
| 3 | Industrials | 6.77% |
| 4 | Financials | 5.63% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCPC
126
Balchem Corporation
BCPC
$5.21B
| $335K | 0.24% |
2,329
-165
| -7% | -$23.7K |
|
127
Marriott International Class A Common Stock
MAR
$71.8B
| $332K | 0.24% |
1,397
| – | – |
|
128
Qualys
QLYS
$4.83B
| $330K | 0.24% |
1,961
-318
| -14% | -$53.6K |
|
129
Moog
MOG.A
$6.21B
| $324K | 0.23% |
2,092
-227
| -10% | -$35.1K |
|
130
Bank of America
BAC
$373B
| $324K | 0.23% |
8,580
+130
| +2% | +$4.91K |
|
131
SM Energy
SM
$3.33B
| $323K | 0.23% |
6,596
-612
| -8% | -$30K |
|
132
Microchip Technology
MCHP
$34.3B
| $322K | 0.23% |
+3,852
| New | +$322K |
|
133
Knife River
KNF
$4.53B
| $321K | 0.23% |
+4,186
| New | +$321K |
|
134
Moelis & Co
MC
$5.28B
| $318K | 0.23% |
5,966
+1,301
| +28% | +$69.2K |
|
135
Global X US Preferred ETF
PFFD
$2.32B
| $316K | 0.23% |
16,295
-2,171
| -12% | -$42.1K |
|
136
Valvoline
VVV
$4.89B
| $314K | 0.23% |
7,507
-375
| -5% | -$15.7K |
|
137
Ollie's Bargain Outlet
OLLI
$7.75B
| $309K | 0.22% |
4,194
-158
| -4% | -$11.6K |
|
138
Ligand Pharmaceuticals
LGND
$3.19B
| $308K | 0.22% |
+4,497
| New | +$308K |
|
139
Cohen & Steers
CNS
$3.64B
| $304K | 0.22% |
4,382
-293
| -6% | -$20.3K |
|
140
CRH
CRH
$74.7B
| $303K | 0.22% |
3,907
-1,437
| -27% | -$112K |
|
141
Lamb Weston
LW
$7.88B
| $298K | 0.22% |
3,625
-318
| -8% | -$26.1K |
|
142
Ultrapar
UGP
$3.88B
| $292K | 0.21% |
56,263
+35,818
| +175% | +$186K |
|
143
UFP Technologies
UFPT
$1.6B
| $291K | 0.21% |
+1,368
| New | +$291K |
|
144
Crane NXT
CXT
$3.4B
| $290K | 0.21% |
+4,690
| New | +$290K |
|
145
Costco
COST
$416B
| $288K | 0.21% |
402
| – | – |
|
146
WNS Holdings
WNS
$3.24B
| $285K | 0.21% |
5,950
+1,104
| +23% | +$52.9K |
|
147
Lam Research
LRCX
$123B
| $279K | 0.2% |
321
| – | – |
|
148
Merit Medical Systems
MMSI
$5.37B
| $278K | 0.2% |
+3,796
| New | +$278K |
|
149
Nova
NVMI
$6.97B
| $277K | 0.2% |
+1,704
| New | +$277K |
|
150
UnitedHealth
UNH
$280B
| $270K | 0.2% |
549
-253
| -32% | -$124K |
|